Control Bionics Limited
Control Bionics Limited
Your view on CBL.AX
Overview
What the company does, where it operates, and who runs it.
About Control Bionics Limited
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Jeremy E. Steele
- Headquarters
- 11-13 Pearson Street, Cremorne, VIC, AU
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Jeremy E. Steele
- Headquarters
- 11-13 Pearson Street, Cremorne, VIC, AU
Operating in Australia and North America, Control Bionics Limited and its subsidiaries specialize in the innovation, development, and market introduction of sophisticated assistive communication technologies.
The company's offerings include the NeuroNode Trilogy and NeuroNode3 systems, which empower individuals facing speech and mobility challenges to control computers for speech generation, electronic correspondence, leisure activities, and remote operation of other devices.
Control Bionics also provides Cosmos Connect, a versatile interface capable of managing diverse equipment like wheelchairs, robotic dining aids, and gaming consoles. Additionally, they offer Uno Touch, a dedicated speech-generating device, alongside various other sensors for a broad spectrum of uses.
Founded in 2005, the entity was initially named Control Bionics Holdings Pty Limited before rebranding as Control Bionics Limited in September 2020. The company's base of operations is situated in Camberwell, Australia.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Control Bionics Limited. Starting points for Control Bionics Limited: EPS -AUD 0.02, beta 0.10 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Control Bionics Limited. Control Bionics Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Control Bionics Limited. Trailing twelve-month EPS for Control Bionics Limited stands at -AUD 0.02. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Control Bionics Limited. Control Bionics Limited has reported as a listed company since 2020. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | |
|---|---|---|---|---|---|
| ADR.AXAdherium Limited | Healthcare | Medical - Devices | — | ||
| BGT.AXBio-Gene Technology Limited | Basic Materials | Agricultural Inputs | — | ||
| CHM.AXChimeric Therapeutics Limited | Healthcare | Biotechnology | — | ||
| ICR.AXIntelicare Holdings Limited | Healthcare | Medical - Healthcare Information Services | — | ||
| IME.AXImExHS Limited | Healthcare | Medical - Diagnostics & Research | — | ||
| NTI.AXNeurotech International Limited | Healthcare | Biotechnology | — | ||
| PAB.AXPatrys Limited | Healthcare | Biotechnology | — | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| CBLLCeriBell, Inc. | Healthcare | NASDAQ | $995.3M | ||
| CERSCerus Corporation | Healthcare | NASDAQ | $391.8M | ||
| CGHCCapital Group Holdings, Inc. | Healthcare | OTC | $9,220 | ||
| CHEOFCochlear Limited | Healthcare | OTC | $8.9B | ||
| CHEOYCochlear Limited | Healthcare | OTC | $9.2B | ||
| CHYPFHealth Logic Interactive Inc. | Healthcare | OTC | $165,839 | ||
| CLLKFBICO Group AB (publ) | Healthcare | OTC | $123.3M | ||
| CLPTClearPoint Neuro, Inc. | Healthcare | NASDAQ | $247.1M | ||
| CLVSFCellaVision AB (publ) | Healthcare | OTC | $378.0M | ||
| CMP.AXCompumedics Limited | Healthcare | ASX | — | ||
| CNMDCONMED Corporation | Healthcare | NYSE | $1.4B | ||
| CNVIFConavi Medical Corp. | Healthcare | OTC | $20.7M | ||
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Control Bionics Limited. Coverage tracks Control Bionics Limited within Medical - Devices (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Control Bionics Limited.